The most comprehensive study to date suggests an estimated 2.4 million Americans have clinically diagnosed inflammatory bowel disease, and up to 56,000 new cases are diagnosed each year.
Freeze-dried, encapsulated fecal microbiota transplantation (FMT) has a safety and effectiveness profile similar to that of liquid colonic FMT, without the procedural risks of colonoscopy.
The challenge of diagnosing and treating persistent abdominal pain can be tackled by greater awareness of the multiple potential causes of this relatively common condition, suggests a French review.
Despite similar outcomes, patients with nonconstipated irritable bowel syndrome found traditional dietary advice easier to follow than the other options.